Graham McClorey
Senior Post Doctoral Researcher/Team Leader
The current focus is understanding and improving upon cell penetrating peptide design to enhance the therapeutic potential of antisense oligonucleotides, in particular for neuromuscular disorders. I am also studying the potential benefit of stereopure oligonucleotides in a severe model of DMD (DKO) through collaboration with Wave LifeSciences.
